FWIA
PCRX icon

Fort Washington Investment Advisors’s Pacira BioSciences PCRX Stock Holding History

Fort Washington Investment Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-462,768
Closed -$13.2M – 415
2024
Q2 		$13.2M Buy
+462,768
New +$13.2M 0.09% 192

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fort Washington Investment Advisors's PCRX Position: Q3 2024 in Review

Fort Washington Investment Advisors sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 462,768 shares — an estimated $13.2M sold.

Fort Washington Investment Advisors first reported a position in PCRX in Q2 2024 and held it in 1 quarter. The position peaked at $13.2M in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Fort Washington Investment Advisors reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 462,768 Pacira BioSciences shares in Q3 2024, an estimated $13.2M.
  • Fort Washington Investment Advisors first reported a position in Pacira BioSciences in Q2 2024 and held it in 1 quarter.
  • Fort Washington Investment Advisors's Pacira BioSciences position peaked at $13.2M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Fort Washington Investment Advisors's 13F filing for Q3 2024, filed 25 Oct 2024.